4 completed, 2 active not recruiting. 6 Phase 2.
By phase and status
Follow Epothilones: new trials by email Literature Review of Epothilones trials Research Report on Epothilones
Trials (filtered) newest first · largest first
All 6 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Ixabepilone, Laboratory Biomarker Analysis - Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Phase 2 Completed 42 2010-09-07 2019-08-08 Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Bevacizumab, Carboplatin, Ixabepilone - Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma Phase 2 Active not recruiting 349 2009-09-14 2026-11-13 Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy Best Practice, Ixabepilone - Bilateral Breast Carcinoma, HER2/Neu Negative Phase 2 Active not recruiting 116 2009-03-30 2026-11-10 A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer ixabepilone, docetaxel, trastuzumab - Metastatic Breast Cancer Phase 2 Completed 50 2008-02-01 2016-03-10 Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer Ixabepilone, Paclitaxel, Cyclophosphamide - Breast Cancer Phase 2 Completed 384 2007-10-01 2016-02-24 A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy Epothilone - Carcinoma, Non-small-cell Lung Phase 2 Completed 2001-02-01 2016-02-10
Conditions studied Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1)
Sponsors National Cancer Institute (NCI) (2) · R-Pharm (2) · Bristol-Myers Squibb (1) · M.D. Anderson Cancer Center (1)
Countries United States (5) · France (2) · Italy (2) · Spain (2) · Argentina (1) · Austria (1) · Germany (1) · Greece (1) · India (1) · Peru (1) · Philippines (1) · Russia (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Top investigators Carol Aghajanian (1) · Carolyn McCourt (1) · Funda Meric-Bernstam (1)
Results publications PMID 25913905 , PMID 27312051 , PMID 33541735 , PMID 35658479
NIH funding U10CA027469 (2) , U10CA180868 (2)